Arginine-glycine-aspartic acid peptide matrix gel - Telios Pharmaceuticals
Alternative Names: Argidene Gel; RGD peptide matrix gel - Telios Pharmaceuticals; Telio-Derm GelLatest Information Update: 07 Nov 2000
At a glance
- Originator Telios Pharmaceuticals
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetic foot ulcer
Most Recent Events
- 07 Nov 2000 No-Development-Reported for Diabetic foot ulcer in USA (Topical)
- 20 Feb 1997 Preregistration for Diabetic foot ulcer in USA (Topical)